- Case Study -

Nukute

The number of methods to pre-screen and diagnose obstructive sleep apnea is very limited although it causes huge direct and indirect economic cost. In addition, the current methods to treat OSA are cumbersome and expensive.

50
k€ in funding
Funding instrument Horizon 2020 SME instrument phase 1
H2020 Topic Clinical research for the validation of biomarkers and/or diagnostic medical devices
Website nukute.com/

Nukute has developed a novel, convenient and cost effective technology to pre-screen and assist in treatment of obstructive sleep apnea (OSA) – potentially serious sleep disorder in which breathing repeatedly stops and starts during sleep. To explore the feasibility of market entry to the U.S., Spinverse helped Nukute to apply for funding.

How we reached the goals

Spinverse strongly supported in project planning, proposal writing and evaluation of the quality of the proposal before submission.

Key takeaways

Nukute has developed a cost-effective wireless system, based on microphone and accelerometers, equipped with a user-friendly mobile app.

The project aims to explore the feasibility of market entry to the U.S. in the pre-screening and treatment device markets.

Read our post on Nukute!

- Contact us -

Want to learn more how Spinverse could help you? Contact us now!



Riikka Paasikivi

Senior Consultant, M.Sc. (Chem.Eng.) +358 50 521 5944

- Case Studies -

Similar case studies

Health & Electronics

Electronics packaging ecosystem

Increasing the competitiveness and global market share of the European semiconductor industry and accelerating the manufacturing uptake of the new technologies

Health & Electronics

Energy harvesting with MEMS

Energy harvesting demonstration project – Creating a new value chain for developing pacemakers with energy harvesting technology with Silex smart-MEMPHIS project – From research over desi...

Health & Electronics

Pilot nano-pharma production

Manufacturing the next generation of pharmaceuticals – Our expertise in successful project proposals helped secure €6.3 million in funding for a pilot plant to produce polymer-based nano-...